IRCT201011151774N3 IRCT 2010-12-29 Kerman medical university acrabose effect on weight loseing Evaluation of effect of acarbose consumption on weight loosing in nondiabetic obese patients in Kerman 2009-03-21 anticipated 66 Complete https://irct.ir/trial/1348 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment. 2-3 overweight. Intervention 1: placebo three tablets daily. Intervention 2: acarbose tablet 100 mg three tablets daily.

public Dr Akram Nakhaee

Kerman ,Kerman Medical university

Kerman Iran (Islamic Republic of) +98 34 1245 3189 anakheai@gmail.com Kerman Medical university scientific Dr Mojgan Sanjari

Kerman, Kerman Medical university

Kerman Iran (Islamic Republic of) +98 34 1322 2250 msanjari@kmu.ac.ir kerman medical university Iran (Islamic Republic of) Inclusion criteria were age equal or more than 18 years, willingness to participate in the study, BMI (weight[kg]/ height[m]2 ) between 25-35, no evidence of cardiovascular disease, diabetes, gastrointestinal disease (IBD, intestinal ulcers, bowel obstruction), liver disease and renal disease, no history of medication for lowering weight, women should not be pregnant or milking. The exclusion criteria were no desire to continue the treatment, development of renal, gastrointestinal and liver disease during treatment and beginning to utilize antihypertensive drugs such as β blocker and thiazides. 18 years 149 years Both E66.9 Obesity, unspecified Placebo Treatment - Drugs placebo three tablets daily acarbose tablet 100 mg three tablets daily BMI. Timepoint: monthly. Method of measurement: meter and weighting scale. Fbs, TG, Cholestrol. Timepoint: every three mounth. Method of measurement: lab test. Excir company Kerman medical university Excir company Approved 2009-07-24 Kerman medical univercity ethics committe Kerman Jomhori ave. Kerman medical univercity Kerman Iran (Islamic Republic of)